Phase I dose escalation clinical trial of phenylbutyrate sodium administered twice daily to patients with advanced solid tumors.
第一作者:
Luis H,Camacho
第一单位:
Department of Medicine, Memorial Sloan-Kettering Cancer Center, Joan and Sanford I. Weill Medical College of Cornell Medical Center, New York, New York, USA.
作者:
主题词
成年人(Adult);老年人(Aged);抗肿瘤药(Antineoplastic Agents);生物转化(Biotransformation);疾病恶化(Disease Progression);剂量效应关系, 药物(Dose-Response Relationship, Drug);女(雌)性(Female);人类(Humans);输注, 静脉内(Infusions, Intravenous);男(雄)性(Male);中年人(Middle Aged);肿瘤(Neoplasms);丁酸苯酯类(Phenylbutyrates);治疗结果(Treatment Outcome)
DOI
10.1007/s10637-006-9017-4
PMID
17053987
发布时间
2018-11-13
- 浏览36
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文